Secured Convertible Note Sample Contracts

GT Biopharma, Inc. – SECURED CONVERTIBLE NOTE DUE AUGUST 2, 2019 (February 6th, 2019)

THIS CONVERTIBLE NOTE is one of a series of duly authorized and validly issued Notes of GT BIOPHARMA, INC., a Delaware corporation, (the “Borrower”), having its principal place of business at 310 N. Westlake Blvd, Suite 206, Westlake Village, CA 91362, due August 2, 2019 (this note, the “Note” and, collectively with the other notes of such series, the “Notes”).

Omni Shrimp, Inc. – SECURED CONVERTIBLE NOTE DUE January 11, 2021 (January 25th, 2019)

THIS CONVERTIBLE NOTE is one of a series of duly authorized and validly issued Notes of Omni Shrimp, Inc., a Nevada corporation, (the “Borrower”), having its principal place of business at 517 Dumaine, PH4, New Orleans, LA 70116, due January 11, 2021 (this note, the “Note” and, collectively with the other notes of such series, the “Notes”).

Applied Dna Sciences Inc – FORM OF SECURED CONVERTIBLE NOTE (December 10th, 2018)

FOR VALUE RECEIVED, Applied DNA Sciences, Inc., a Delaware corporation (the “Company”), hereby promises to pay to [___________________] or registered assigns (“Holder”) the amount set out above as the Original Principal Amount (as reduced pursuant to the terms hereof pursuant to redemption, conversion or otherwise, the “Principal”) when due, whether upon the Maturity Date (as defined below), acceleration, redemption or otherwise (in each case in accordance with the terms hereof) and to pay interest (“Interest”) on any outstanding Principal at the applicable Interest Rate from the date set out above as the Issuance Date (the “Issuance Date”) until the same becomes due and payable, whether upon an Interest Date (as defined below), the Maturity Date, acceleration, redemption, conversion or otherwise (in each case in accordance with the terms hereof). This Secured Convertible Note (including all Secured Convertible Notes issued in exchange, transfer or replacement hereof, this “Note”) is o

Applied Dna Sciences Inc – FORM OF SECURED CONVERTIBLE NOTE (December 6th, 2018)

FOR VALUE RECEIVED, Applied DNA Sciences, Inc., a Delaware corporation (the “Company”), hereby promises to pay to [___________________] or registered assigns (“Holder”) the amount set out above as the Original Principal Amount (as reduced pursuant to the terms hereof pursuant to redemption, conversion or otherwise, the “Principal”) when due, whether upon the Maturity Date (as defined below), acceleration, redemption or otherwise (in each case in accordance with the terms hereof) and to pay interest (“Interest”) on any outstanding Principal at the applicable Interest Rate from the date set out above as the Issuance Date (the “Issuance Date”) until the same becomes due and payable, whether upon an Interest Date (as defined below), the Maturity Date, acceleration, redemption, conversion or otherwise (in each case in accordance with the terms hereof). This Secured Convertible Note (including all Secured Convertible Notes issued in exchange, transfer or replacement hereof, this “Note”) is o

Intellinetics, Inc. – AMENDMENT to 8% SECURED CONVERTIBLE NOTE DUE NOVEMBER 30, 2019 (September 20th, 2018)

This Amendment (“Amendment”) to the 8% Secured Convertible Notes due November 30, 2019, dated November 17, 2017 and November 29, 2017 (the “Notes”) is entered into and effective as of the last date indicated below, by and between Intellinetics, Inc., a Nevada corporation (the “Company”) and the holders of the Notes (the “Holders”).

Applied Dna Sciences Inc – Applied DNA Announces Closing of $1.65 Million Private Placement of Secured Convertible Notes (September 4th, 2018)

STONY BROOK, N.Y., September 4, 2018 –Applied DNA Sciences Inc., (NASDAQ: APDN, “Applied DNA” or the “Company”), the leader in large-scale PCR-based DNA manufacturing, today announced the closing in the amount of $1.65 million of secured convertible notes (the “Notes”) by way of a non-brokered private placement with accredited investors and certain members of its management team and Board of Directors, led by its Chairman, President and Chief Executive Officer. The Company expects to use the proceeds for general corporate purposes.

XpresSpa Group, Inc. – AMENDMENT AGREEMENT TO SECURED CONVERTIBLE NOTE DUE NOVEMBER 16, 2019 (August 14th, 2018)

This Amendment Agreement (this “Amendment”) to the Secured Convertible Note due November 16, 2019 (the “Note”), is made and entered into as of August 14, 2018, among XpresSpa Group, Inc., a Delaware corporation (the “Company”), and the Holder (as identified on the signature page hereto). Capitalized terms used herein but not defined shall have the meaning ascribed to such terms in the Note.

MaxQ AI Ltd. – SECURED CONVERTIBLE NOTE DUE DECEMBER __, 2018 (August 9th, 2018)

THIS CONVERTIBLE NOTE is one of a series of duly authorized and validly issued Notes of MEDYMATCH TECHNOLOGY LTD., a company incorporated under the laws of the State of Israel (the “Borrower”), having its principal place of business at 76 Yigal Alon Street, Floor 5, Tel Aviv, Israel 6706701, due December 29, 2018, subject to acceleration and extension as described herein (this note, the “Note” and, collectively with the other notes of such series, the “Notes”).

Medite Cancer Diagnostics, Inc. – 12% SECURED CONVERTIBLE NOTE (July 13th, 2018)

THIS 12% SECURED CONVERTIBLE NOTE is issued by MEDITE CANCER DIAGNOSTICS, INC., a Delaware corporation (the “Company”) (this note, the “Note”).

Immudyne, Inc. – SECURED CONVERTIBLE NOTE DUE MAY 29, 2019 (June 1st, 2018)

THIS CONVERTIBLE NOTE is one of a series of duly authorized and validly issued Notes of IMMUDYNE, INC., a Delaware corporation, (the “Borrower”), having its principal place of business at 1460 Broadway, New York, NY 10036, fax: [REQUIRES COMPLETION], due May 29, 2019 (this note, the “Note” and, collectively with the other notes of such series, the “Notes”).

XpresSpa Group, Inc. – SECURED CONVERTIBLE NOTE DUE NOVEMBER __, 2019 (May 15th, 2018)

THIS CONVERTIBLE NOTE is one of a series of duly authorized and validly issued Notes of XPRESSPA GROUP, INC., a Delaware corporation, (the “Borrower”), having its principal place of business at 780 Third Avenue, 12th Floor, New York, NY 10017, due November__, 2019 (this note, the “Note” and, collectively with the other notes of such series, the “Notes”).

XpresSpa Group, Inc. – XpresSpa Group Reports First Quarter 2018 Results Product and Service Revenue Grew 7.4% Adjusted EBITDA Loss Narrowed Continuing Cost Reduction Enters into $4.4 Million Secured Convertible Notes Extends Maturity of Existing Debt to December 31, 2019 (May 15th, 2018)

NEW YORK, May 15, 2018 - XpresSpa Group, Inc. (Nasdaq: XSPA), a health and wellness holding company, today announced financial results for the first quarter ended March 31, 2018. Following the sale of Group Mobile on March 22, 2018, the Company determined that it only had one operating segment, and first quarter 2018 and 2017 results are presented accordingly.

Intellinetics, Inc. – AMENDMENT to 8% SECURED CONVERTIBLE NOTE DUE NOVEMBER 30, 2009 (May 1st, 2018)

This Amendment (“Amendment”) to the 8% Secured Convertible Notes due November 30, 2009, dated November 17, 2017 and November 29, 2017 (the “Notes”) is entered into and effective as of the last date indicated below, by and between Intellinetics, Inc., a Nevada corporation (the “Company”) and the holders of the Notes (the “Holders”).

Intellinetics, Inc. – AMENDMENT to 8% SECURED CONVERTIBLE NOTE DUE NOVEMBER 30, 2009 (April 2nd, 2018)

This Amendment (“Amendment”) to the 8% Secured Convertible Notes due November 30, 2009, dated November 17, 2017 and November 29, 2017 (the “Notes”) is entered into and effective as of the last date indicated below, by and between Intellinetics, Inc., a Nevada corporation (the “Company”) and the holders of the Notes (the “Holders”).

Medite Cancer Diagnostics, Inc. – 12% SECURED CONVERTIBLE NOTE (February 12th, 2018)

THIS 12% SECURED CONVERTIBLE NOTE is issued by MEDITE CANCER DIAGNOSTICS, INC., a Delaware corporation (the “Company”) (this note, the “Note”).

Integrated Ventures, Inc. – Crypto Currency Secured Convertible Note Investment (December 28th, 2017)

$35,000 of the funding amount shall be allocated by the Company for the legal fees associated with the filing of the S-1 Registration Statement.

Intellinetics, Inc. – 8% Secured CONVERTIBLE NOTE DUE November 30, 2019 (November 24th, 2017)

THIS 8% SECURED CONVERTIBLE NOTE is one of a series of duly authorized and validly issued 8% Secured Convertible Notes of Intellinetics, Inc., a Nevada corporation, (the “Company”), having its principal place of business at 2190 Dividend Drive, Columbus, OH 43228, designated as its 8% Secured Convertible Note due November 30, 2019 (this Note, the “Note” and, collectively with the other Notes of such series, the “Notes”).

Reign Sapphire Corp – SECURED CONVERTIBLE NOTE DUE MAY 10, 2019 (November 16th, 2017)

THIS CONVERTIBLE NOTE is one of a series of duly authorized and validly issued Notes of REIGN SAPPHIRE CORPORATION, a Delaware corporation, (the “Borrower”), having its principal place of business at 9465 Wilshire Boulevard, Beverly Hills, CA 90212, due May 10, 2019 (this note, the “Note” and, collectively with the other notes of such series, the “Notes”).

Andalay Solar, Inc. – SECURED CONVERTIBLE NOTE DUE OCTOBER 2, 2019 (October 11th, 2017)

THIS SECURED CONVERTIBLE NOTE is a duly authorized and validly issued Note of Andalay Solar, Inc., a Delaware corporation, (the “Borrower”), having its principal place of business at 2071 Ringwood Avenue, Unit C, San Jose, CA 95131, due October 2, 2019 (the “Note”).

Medite Cancer Diagnostics, Inc. – 13.25% SECURED CONVERTIBLE NOTE (October 2nd, 2017)

THIS 13.25% SECURED CONVERTIBLE NOTE is issued at a 2.5% original issue discount by MEDITE CANCER DIAGNOSTICS, INC., a Delaware corporation (the “Company”) (this note, the “Note”).

Friendable, Inc. – SECURED CONVERTIBLE NOTE DUE JULY 21, 2018 (August 2nd, 2017)

THIS CONVERTIBLE NOTE is one of a series of duly authorized and validly issued Notes of FRIENDABLE, INC., a Nevada corporation, (the “Borrower”), having its principal place of business at 125 East Campbell Avenue, 2nd Floor, Campbell CA 95008, due July 21, 2018 (this note, the “Note” and, collectively with the other notes of such series, the “Notes”).

Argos Therapeutics Inc – Argos Therapeutics Announces $6,000,000 Secured Convertible Note Financing (June 16th, 2017)

This press release does not constitute an offer to sell or the solicitation of an offer to buy the Securities, nor shall there be any sale of the Securities in any state in which such offer, solicitation or sale would be unlawful prior to the registration or qualification under the securities laws of such state. Any offering of the Securities under the resale registration statement will only be by means of a prospectus.

Enerpulse Technologies, Inc. – [FORM OF SENIOR SUBORDINATED SECURED CONVERTIBLE NOTE] (February 2nd, 2017)

FOR VALUE RECEIVED, Enerpulse Technologies, Inc., a Nevada corporation (the “Company”), hereby promises to pay to [buyer] or registered assigns (the “Holder”) in cash and/or in shares of Common Stock (as defined below) the amount set out above as the Original Principal Amount (as reduced pursuant to the terms hereof pursuant to redemption, conversion or otherwise, the “Principal”) when due, whether upon the Maturity Date (as defined below), acceleration, redemption or otherwise (in each case in accordance with the terms hereof) and to pay interest (“Interest”) on any outstanding Principal at the applicable Interest Rate from the date set out above as the Issuance Date (the “Issuance Date”) until the same becomes due and payable, whether upon the Maturity Date, acceleration, conversion, redemption or otherwise (in each case in accordance with the terms hereof). This Senior Subordinated Secured Convertible Note (including all Senior Subordinated Secured Convertible Notes issued in exchan

Enerpulse Technologies, Inc. – [FORM OF AMENDED AND RESTATED SENIOR SUBORDINATED SECURED CONVERTIBLE NOTE] (February 2nd, 2017)

FOR VALUE RECEIVED, Enerpulse Technologies, Inc., a Nevada corporation (the “Company”), hereby promises to pay to [buyer] or registered assigns (the “Holder”) in cash and/or in shares of Common Stock (as defined below) the amount set out above as the Original Principal Amount (as reduced pursuant to the terms hereof pursuant to redemption, conversion or otherwise, the “Principal”) when due, whether upon the Maturity Date (as defined below), acceleration, redemption or otherwise (in each case in accordance with the terms hereof) and to pay interest (“Interest”) on any outstanding Principal at the applicable Interest Rate from the date set out above as the Issuance Date (the “Issuance Date”) until the same becomes due and payable, whether upon the Maturity Date, acceleration, conversion, redemption or otherwise (in each case in accordance with the terms hereof). This Amended and Restated Senior Subordinated Secured Convertible Note (including all notes issued in exchange, transfer or rep

Enerpulse Technologies, Inc. – SENIOR SUBORDINATED SECURED CONVERTIBLE NOTE AMENDMENT AGREEMENT AND WAIVER (February 2nd, 2017)

THIS SUBORDINATED SENIOR SECURED CONVERTIBLE NOTE AMENDMENT AGREEMENT AND WAIVER (this “Agreement”) is made and entered into as of January 26, 2017, by and between Enerpulse Technologies, Inc., a Nevada corporation (the “Company”), and the noteholder listed on the signature page hereto (the “Noteholder”).

Enerpulse Technologies, Inc. – [FORM OF AMENDED AND RESTATED SENIOR SUBORDINATED SECURED CONVERTIBLE NOTE] (February 2nd, 2017)

FOR VALUE RECEIVED, Enerpulse Technologies, Inc., a Nevada corporation (the “Company”), hereby promises to pay to [buyer] or registered assigns (the “Holder”) in cash and/or in shares of Common Stock (as defined below) the amount set out above as the Original Principal Amount (as reduced pursuant to the terms hereof pursuant to redemption, conversion or otherwise, the “Principal”) when due, whether upon the Maturity Date (as defined below), acceleration, redemption or otherwise (in each case in accordance with the terms hereof) and to pay interest (“Interest”) on any outstanding Principal at the applicable Interest Rate from the date set out above as the Issuance Date (the “Issuance Date”) until the same becomes due and payable, whether upon the Maturity Date, acceleration, conversion, redemption or otherwise (in each case in accordance with the terms hereof). This Amended and Restated Senior Subordinated Secured Convertible Note (including all notes issued in exchange, transfer or rep

Imaging3 Inc – SECURED CONVERTIBLE NOTE Due AUGUST 31, 2017 (January 12th, 2017)

THIS SECURED CONVERTIBLE NOTE is a duly authorized and validly issued Secured Convertible Note of Imaging3, Inc., a California corporation, (the “Company”), having its principal place of business at 3200 Valhalla Drive, Burbank, CA 91505 designated as its 10% Secured OID Convertible Note (the “Note”).

Protalix BioTherapeutics, Inc. – Protalix BioTherapeutics Announces Private Note Exchanges and Private Placement of Secured Convertible Notes due 2021 (December 2nd, 2016)

CARMIEL, Israel, December 1, 2016 //GlobeNewswire - Protalix BioTherapeutics, Inc. (NYSE MKT:PLX, TASE:PLX) (the “Company”) announced today the entry into a definitive exchange agreement relating to an exchange (the “Exchange”) of $54.1 million principal amount of the Company’s outstanding 4.50% Senior Convertible Notes due 2018 (the “Existing Notes”) for (i) $40.2 million principal amount of newly issued 7.50% Senior Secured Convertible Notes due 2021 (the “Notes”) and (ii) approximately 23.8 million shares of common stock, $0.001 par value per share (“Common Stock”). Concurrently, the Company announced the entry into a definitive note purchase agreement with commitments to issue and sell, in a private placement, $22.5 million principal amount of the Notes (the “Private Placement”) to qualified institutional buyers as defined in Rule 144A under the Securities Act of 1933, as amended (the “Securities Act”). The Exchange and the Private Placement are expected to close concurrently on De

Reign Sapphire Corp – SECURED CONVERTIBLE NOTE DUE MAY 10, 2018 (November 14th, 2016)

THIS CONVERTIBLE NOTE is one of a series of duly authorized and validly issued Notes of REIGN SAPPHIRE CORPORATION, a Delaware corporation, (the “Borrower”), having its principal place of business at 9465 Wilshire Boulevard, Beverly Hills, CA 90212, due May 10, 2018 (this note, the “Note” and, collectively with the other notes of such series, the “Notes”).

Onstream Media CORP – AMENDMENT AND ALLONGE TO SECOND AMENDED AND RESTATED SENIOR SUBORDINATED SECURED CONVERTIBLE NOTE (October 28th, 2016)

This AMENDMENT AND ALLONGE (this “Amendment”), effective as of November 24, 2015, is by and among ONSTREAM MEDIA CORPORATION (the “Company”), INFINITE CONFERENCING, INC. (“ICI”), ENTERTAINMENT DIGITAL NETWORK, INC. (“EDNI”), AV ACQUISITION, INC. (“AAI”), ONSTREAM CONFERENCING CORPORATION (“OCC”), MEDIA ON DEMAND, INC. (“MOD”), HOTEL VIEW CORPORATION (“HVC”), OSM ACQUISITION INC. (“OSM”) and AUCTION VIDEO JAPAN, INC. (“AVJI”) (the Company, ICI, EDNI, AAI, OCC, MOD, HVC, OSM and AVJI shall be referred to collectively as the “Borrowers”) and SIGMA OPPORTUNITY FUND II, LLC (the “Holder”).

Onstream Media CORP – THIRD AMENDMENT AND ALLONGE TO SECOND AMENDED AND RESTATED SENIOR SUBORDINATED SECURED CONVERTIBLE NOTE (October 28th, 2016)

This THIRD AMENDMENT AND ALLONGE (this “Amendment”), effective as of December 22, 2015, is by and among ONSTREAM MEDIA CORPORATION (the “Company”), INFINITE CONFERENCING, INC. (“ICI”), ENTERTAINMENT DIGITAL NETWORK, INC. (“EDNI”), AV ACQUISITION, INC. (“AAI”), ONSTREAM CONFERENCING CORPORATION (“OCC”), MEDIA ON DEMAND, INC. (“MOD”), HOTEL VIEW CORPORATION (“HVC”), OSM ACQUISITION INC. (“OSM”) and AUCTION VIDEO JAPAN, INC. (“AVJI”) (the Company, ICI, EDNI, AAI, OCC, MOD, HVC, OSM and AVJI shall be referred to collectively as the “Borrowers”) and SIGMA OPPORTUNITY FUND II, LLC (the “Holder”).

Onstream Media CORP – AMENDMENT AND ALLONGE TO SECOND AMENDED AND RESTATED SENIOR SUBORDINATED SECURED CONVERTIBLE NOTE (October 28th, 2016)

This AMENDMENT AND ALLONGE (this “Amendment”), effective as of November 16, 2015, is by and among ONSTREAM MEDIA CORPORATION (the “Company”), INFINITE CONFERENCING, INC. (“ICI”), ENTERTAINMENT DIGITAL NETWORK, INC. (“EDNI”), AV ACQUISITION, INC. (“AAI”), ONSTREAM CONFERENCING CORPORATION (“OCC”), MEDIA ON DEMAND, INC. (“MOD”), HOTEL VIEW CORPORATION (“HVC”), OSM ACQUISITION INC. (“OSM”) and AUCTION VIDEO JAPAN, INC. (“AVJI”) (the Company, ICI, EDNI, AAI, OCC, MOD, HVC, OSM and AVJI shall be referred to collectively as the “Borrowers”) and SIGMA OPPORTUNITY FUND II, LLC (the “Holder”).

Digital Power Corp – 12% SECURED CONVERTIBLE NOTE DUE OCTOBER 20, 2019 (October 27th, 2016)

THIS NOTE IS ISSUED PURSUANT TO AN EXEMPTION FROM THE REGISTRATION PROVISIONS OF THE SECURITIES ACT OF 1933 (THE "ACT") AND QUALIFICATION PROVISIONS OF APPLICABLE STATE SECURITIES LAWS. NEITHER IT NOR THE SHARES OF COMMON STOCK INTO WHICH IT CAN BE CONVERTED CAN BE SOLD, HYPOTHECATED OR OTHERWISE TRANSFERRED UNLESS REGISTERED PURSUANT TO THE ACT AND QUALIFIED UNDER APPLICABLE STATE LAW OR, IN THE OPINION OF COUNSEL REASONABLY SATISFACTORY TO MAKER, AN EXEMPTION THEREFROM IS AVAILABLE.

Sigma Labs, Inc. – FORM OF ORIGINAL ISSUE DISCOUNT 10% SECURED CONVERTIBLE NOTE DUE OCTOBER 17, 2017 (October 20th, 2016)

THIS 10% SECURED CONVERTIBLE NOTE (the “Note) is issued at an approximately 10.0% original issue discount (resulting in the lending of $_______) by Sigma Labs, Inc., a Nevada corporation (the “Company”).

Accelerated Pharma, Inc. – SECURED CONVERTIBLE NOTE DUE JUNE 23, 2016 (October 11th, 2016)

THIS CONVERTIBLE NOTE is one of a series of duly authorized and validly issued Notes of ACCELERATED PHARMA, INC., a Delaware corporation, (the “Borrower”), having its principal place of business at 15W155 81st Street, Burr Ridge, IL 60527, Fax: (630) 325-4179, due June 23, 2016 (this note, the “Note” and, collectively with the other notes of such series, the “Notes”).